Sabra Health Care REIT, Inc. (SBRA)
- Previous Close
17.51 - Open
17.58 - Bid 12.69 x 200
- Ask 22.47 x 200
- Day's Range
17.47 - 17.97 - 52 Week Range
13.82 - 20.03 - Volume
1,800,199 - Avg. Volume
2,514,304 - Market Cap (intraday)
4.247B - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
33.06 - EPS (TTM)
0.54 - Earnings Date May 5, 2025
- Forward Dividend & Yield 1.20 (6.85%)
- Ex-Dividend Date Feb 14, 2025
- 1y Target Est
19.50
As of September 30, 2024, Sabra's investment portfolio included 373 real estate properties held for investment (consisting of (i) 233 skilled nursing/transitional care facilities, (ii) 39 senior housing communities (senior housing - leased), (iii) 68 senior housing communities operated by third-party property managers pursuant to property management agreements (senior housing - managed), (iv) 18 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 14 investments in loans receivable (consisting of three mortgage loans and 11 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2024, Sabra's real estate properties held for investment included 37,793 beds/units, spread across the United States and Canada.
www.sabrahealth.com50
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SBRA
View MorePerformance Overview: SBRA
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBRA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBRA
View MoreValuation Measures
Market Cap
4.17B
Enterprise Value
6.55B
Trailing P/E
32.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.88
Price/Book (mrq)
1.52
Enterprise Value/Revenue
9.31
Enterprise Value/EBITDA
15.88
Financial Highlights
Profitability and Income Statement
Profit Margin
18.03%
Return on Assets (ttm)
3.00%
Return on Equity (ttm)
4.57%
Revenue (ttm)
702.64M
Net Income Avi to Common (ttm)
126.71M
Diluted EPS (ttm)
0.54
Balance Sheet and Cash Flow
Total Cash (mrq)
81.94M
Total Debt/Equity (mrq)
88.50%
Levered Free Cash Flow (ttm)
250.41M